img
Thrombocytopenia due to the use of rifampicin in brucellosis    
Yazarlar
Cengiz Demir
Van Yüzüncü Yıl Üniversitesi, Turkey
Refah Sayin
Van Yüzüncü Yıl Üniversitesi, Turkey
Yasemin Soyoral
Van Yüzüncü Yıl Üniversitesi, Turkey
Prof. Dr. Mustafa Kasım KARAHOCAGİL Prof. Dr. Mustafa Kasım KARAHOCAGİL
Kırşehir Ahi Evran Üniversitesi, Türkiye
Özet
Thrombocytopenia may develop after drug therapy and is a life-threatening condition. Thrombocytopenia may also occur after high-dose use of rifampicin which is an antibiotic. Here, we report five cases of thrombocytopenia developing after the use of rifampicin for the treatment of brucellosis. Four cases had experienced diffuse petechiae and ecchymosis with severe thrombocytopenia. The other patient had a complicated thrombocytopenia with intracerebral hemorrhage. As a result, the usage of rifampicin in the treatment of brucellosis could lead to systemic or central complications.
Anahtar Kelimeler
Brucellosis | Rifampicin | Thrombocytopenia
Makale Türü Özgün Makale
Makale Alt Türü SCOPUS dergilerinde yayımlanan tam makale
Dergi Adı Eastern Journal of Medicine
Dergi ISSN 1301-0883
Makale Dili İngilizce
Basım Tarihi 07-2012
Cilt No 17
Sayı 3
Sayfalar 145 / 148
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
SCOPUS 1

Paylaş